Biohaven Pharmaceutical Holding Co Ltd.

BALYASNY ASSET MANAGEMENT L.P.

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/15/2022

Shares

610,571

Value ($000)

92,300

Weight

0.4%

2020 Q4 - 2022 Q3 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/15/2022	92,300	0.4%	610,571	9/30/2022
2022 Q2	8/15/2022	48,644	0.2%	333,839	6/30/2022
2021 Q3	12/1/2021	4,785	0.0%	34,446	9/30/2021
2020 Q4	2/16/2021	1,168	0.0%	13,627	12/31/2020